Lyophilizable Stem Cell‐Hybrid Liposome with Long‐Term Stability and High Targeting Capacity

Author:

Zhang Tianyuan123ORCID,Zheng Xixi12,Lin Ruyi1,Sun Hao1,Wu Honghui1,Zhang Jinsong1,Chen Shihan12,Li Yaosheng1,Xu Donghang4,Gao Jianqing12345ORCID

Affiliation:

1. College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 China

2. Institute of Innovative Medicine College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 China

3. National Key Laboratory of Advanced Drug Delivery and Release Systems Zhejiang University Hangzhou 310058 China

4. Department of Pharmacy The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China

5. Cancer Center Zhejiang University Hangzhou 310058 China

Abstract

AbstractThe hybridization of liposome with stem cell membranes is an emerging technology to prepare the nanovehicle with the capacity of disease‐responsive targeting. However, the long‐term storage of this hybrid liposome has received limited attention in the literature, which is essential for its potential applicability in the clinic. Therefore, the preservation of long‐term activity of stem cell‐hybrid liposome using freeze‐drying is investigated in the present study. Mesenchymal stem cell‐hybrid liposome is synthesized and its feasibility for freeze‐drying under different conditions is examined. Results reveal that pre‐freezing the hybrid liposome at −20 °C in Tris buffer solution (pH 7.4) containing 10% trehalose can well preserve the liposomal structure for at least three months. Notably, major membrane proteins on the hybrid liposome are protected in this formulation and CXCR4‐associated targeting capacity is maintained both in vitro and in vivo. Consequently, the hybrid liposome stored for three months demonstrates a comparable tumor inhibition as the fresh‐prepared one. The present study provides the first insights into the long‐term storage of stem cell hybrid liposome using lyophilization, which may make an important step forward in enhancing the long‐term stability of these promising biomimetic nanovehicle and ease the logistics and the freeze‐storage in the potential clinical applications.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Fundamental Research Funds for the Central Universities

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3